|
1
|
Zhuang H: Current status and goals of
hepatitis B prevention and treatment. Zhonghua Nei Ke Za Zhi.
47:793–795. 2008.(In Chinese). PubMed/NCBI
|
|
2
|
Shen Zhong-Yang, Zhu Zhi-Jun, Deng
Yong-Lin, Sun Liying, Qu Wei, Rao Wei, Sun Xiao-Ye, Zheng Hong, Pan
Cheng and Liu Yi-He: Combination of low-dose HBIg and Nucleoside
analogues to prevent recurrent hepatitis B virus after liver
transplantation: A retrospective analysis of 1506 cases. Chinese J
Hepatobiliary Surg. 17:364–366. 2011.
|
|
3
|
Avolio AW, Nure E, Pompili M, Barbarino R,
Basso M, Caccamo L, Magalini S, Agnes S and Castagneto M: Liver
transplantation for hepatitis B virus patients: Long-term results
of three therapeutic approaches. Transplant Proc. 40:1961–1964.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Samuel D, Feray C and Bismuth H: Hepatitis
viruses and liver transplantation. J Gastroenterol Hepatol.
12:(Suppl). S335–S341. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Campsen J, Zimmerman M, Trotter J, Hong J,
Freise C, Brown R, Cameron A, Ghobrial M, Kam I, Busuttil R, et al:
Liver transplantation for hepatitis B liver disease and concomitant
hepatocellular carcinoma in the United States with hepatitis B
immunoglobulin and nucleoside/nucleotide analogues. Liver Transpl.
19:1020–1029. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cholongitas E, Goulis J, Akriviadis E and
Papatheodoridis GV: Hepatitis B immunoglobulin and/or nucleos(t)ide
analogues for prophylaxis against hepatitis b virus recurrence
after liver transplantation: A systematic review. Liver Transpl.
17:1176–1190. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ishigami M, Onishi Y, Ito T, Katano Y, Ito
A, Hirooka Y, Kiuchi T and Goto H: Anti-hepatitis B surface
immunoglobulin reduction in early postoperative period after liver
transplantation in hepatitis B virus-positive patients. Hepatol
Res. 41:1189–1198. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Saab S, Ham MY, Stone MA, Holt C and Tong
M: Decision analysis model for hepatitis B prophylaxis one year
after liver transplantation. Liver Transpl. 15:413–420. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen ZY, Zheng WP, Deng YL and Song HL:
Variations in the S and P regions of the hepatitis B virus genome
under immunosuppression in vitro and in vivo. Viral Immunol.
25:368–378. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Limquiaco JL, Wong J, Wong VW, Wong GL,
Tse CH, Chan HY, Kwan KY, Lai PB and Chan HL: Lamivudine
monoprophylaxis and adefovir salvage for liver transplantation in
chronic hepatitis B: A seven-year follow-up study. J Med Virol.
81:224–229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rosenau J, Hooman N, Hadem J, Rifai K,
Bahr MJ, Philipp G, Tillmann HL, Klempnauer J, Strassburg CP and
Manns MP: Failure of hepatitis B vaccination with conventional
HbsAg vaccine in patients with continuous HBIG prophylaxis after
liver transplantation. Liver Transpl. 13:367–373. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wursthorn K, Wedemeyer H and Manns MP:
Managing HBV in patients with impaired immunity. Gut. 59:1430–1445.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han D, Wu C, Xiong Q, Zhou L and Tian Y:
Anti-inflammatory mechanism of bone marrow mesenchymal stem cell
transplantation in rat model of spinal cord injury. Cell Biochem
Biophys. 71:1341–1347. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen ZY, Zhang J, Song HL and Zheng WP:
Bone-marrow mesenchymal stem cells reduce rat intestinal
ischemia-reperfusion injury, ZO-1 downregulation and tight junction
disruption via a TNF-α-regulated mechanism. World J Gastroenterol.
19:3583–3595. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mitkari B, Nitzsche F, Kerkelä E, Kuptsova
K, Huttunen J, Nystedt J, Korhonen M and Jolkkonen J: Human bone
marrow mesenchymal stem/stromal cells produce efficient
localization in the brain and enhanced angiogenesis after
intra-arterial delivery in rats with cerebral ischemia, but this is
not translated to behavioral recovery. Behav Brain Res. 259:50–59.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Santhakumar R, Vidyasekar P and Verma RS:
Cardiogel: A nano-matrix scaffold with potential application in
cardiac regeneration using mesenchymal stem cells. PLoS One.
9:e1146972014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ball LM, Bernardo ME, Roelofs H, Lankester
A, Cometa A, Egeler RM, Locatelli F and Fibbe WE: Cotransplantation
of ex vivo expanded mesenchymal stem cells accelerates lymphocyte
recovery and may reduce the risk of graft failure in haploidentical
hematopoietic stem-cell transplantation. Blood. 110:2764–2767.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Phinney DG and Prockop DJ: Concise review:
Mesenchymal stem/multipotent stromal cells: The state of
transdifferentiation and modes of tissue repair-current views. Stem
Cells. 25:2896–2902. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang W, Shen ZY, Song HL, Yang Y, Wu BJ,
Fu NN and Liu T: Protective effect of bone marrow mesenchymal stem
cells in intestinal barrier permeability after heterotopic
intestinal transplantation. World J Gastroenterol. 20:7442–7451.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Perez-Basterrechea M, Obaya AJ, Meana A,
Otero J and Esteban MM: Cooperation by fibroblasts and bone
marrow-mesenchymal stem cells to improve pancreatic rat-to-mouse
islet xenotransplantation. PLoS One. 8:e735262013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roemeling-van Rhijn M, Khairoun M,
Korevaar SS, Lievers E, Leuning DG, Ijzermans JN, Betjes MG,
Genever PG, van Kooten C, de Fijter HJ, et al: Human bone marrow-
and adipose tissue-derived mesenchymal stromal cells are
immunosuppressive in vitro and in a humanized allograft rejection
model. J Stem Cell Res Ther. (Suppl 6). S207802013.
|
|
22
|
Shi M, Zhang Z, Xu R, Lin H, Fu J, Zou Z,
Zhang A, Shi J, Chen L, Lv S, et al: Human mesenchymal stem cell
transfusion is safe and improves liver function in acute-on-chronic
liver failure patients. Stem Cells Transl Med. 1:725–731. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sells MA, Chen ML and Acs G: Production of
hepatitis B virus particles in Hep G2 cells transfected with cloned
hepatitis B virus DNA. Proc Natl Acad Sci USA. 84:1005–1009. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shen ZY, Zheng WP, Liu T, Yang Y and Song
HL: Effects of dendritic cells from hepatitis B virus transgenic
mice-stimulated autologous lymphocytes on hepatitis B virus
replication: A study on the impact of specific sensitized effector
cells on in vitro virus replication. Viral Immunol. 28:85–92. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao YT, Han T, Li Y, Yang B, Wang YJ, Wang
FM, Jing X and Du Z: Enhanced specificity of real-time PCR for
measurement of hepatitis B virus cccDNA using restriction
endonuclease and plasmid-safe ATP-dependent DNase and selective
primers. J Virol Methods. 169:181–187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Harting M, Jimenez F, Pati S, Baumgartner
J and Cox C Jr: Immunophenotype characterization of rat mesenchymal
stromal cells. Cytotherapy. 10:243–253. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Joshi MB, Patil P, He Z, Holgersson J,
Olausson M and Sumitran-Holgersson S: Fetal liver-derived
mesenchymal stromal cells augment engraftment of transplanted
hepatocytes. Cytotherapy. 14:657–669. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fouraschen SM, Pan Q, de Ruiter PE, Farid
WR, Kazemier G, Kwekkeboom J, Ijzermans JN, Metselaar HJ, Tilanus
HW, de Jonge J and van der Laan LJ: Secreted factors of human
liver-derived mesenchymal stem cells promote liver regeneration
early after partial hepatectomy. Stem Cells Dev. 21:2410–2419.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fouraschen SM, Hall SR, de Jonge J and van
der Laan LJ: Support of hepatic regeneration by trophic factors
from liver-derived mesenchymal stromal/stem cells. Methods Mol
Biol. 1213:89–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Oh SH, Hatch HM and Petersen BE: Hepatic
oval ‘stem’ cell in liver regeneration. Semin Cell Dev Biol.
13:405–409. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Facciorusso A, Antonino M, Del Prete V,
Neve V, Scavo MP and Barone M: Are hematopoietic stem cells
involved in hepatocarcinogenesis? Hepatobiliary Surg Nutr.
3:199–206. 2014.PubMed/NCBI
|
|
32
|
Lehwald N, Duhme C, Wildner M, Kuhn S,
Fürst G, Forbes SJ, Jonas S, Robson SC, Knoefel WT, Schmelzle M and
Schulte Am Esch J: HGF and SDF-1-mediated mobilization of CD133+
BMSC for hepatic regeneration following extensive liver resection.
Liver Int. 34:89–101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zocco MA, Piscaglia AC, Giuliante F, Arena
V, Novi M, Rinninella E, Tortora A, Rumi C, Nuzzo G, Vecchio FM, et
al: CD133+ stem cell mobilization after partial hepatectomy depends
on resection extent and underlying disease. Dig Liver Dis.
43:147–154. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hosseini M, Moghadas M, Edalatmanesh MA
and Hashemzadeh MR: Xenotransplantation of human adipose derived
mesenchymal stem cells in a rodent model of Huntington's disease:
Motor and non-motor outcomes. Neurol Res. 37:309–319. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao F, Li Q, Hou L, Li Z, Min F and Liu Z:
Mesenchymal stem cell-based angiotensin-converting enzyme 2 in
treatment of acute lung injury rat induced by bleomycin. Exp Lung
Res. 40:392–403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Khabbal J, Kerkelä E, Mitkari B, Raki M,
Nystedt J, Mikkonen V, Bergström K, Laitinen S, Korhonen M and
Jolkkonen J: Differential clearance of rat and human bone
marrow-derived mesenchymal stem cells from the brain after
intra-arterial infusion in rats. Cell Transplant. 24:819–828. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chuang CK, Lin KJ, Lin CY, Chang YH, Yen
TC, Hwang SM, Sung LY, Chen HC and Hu YC: Xenotransplantation of
human mesenchymal stem cells into immunocompetent rats for
calvarial bone repair. Tissue Eng Part A. 16:479–488. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Y, Chen X, Armstrong MA and Li G:
Survival of bone marrow-derived mesenchymal stem cells in a
xenotransplantation model. J Orthop Res. 25:926–932. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jorgensen C, Djouad F, Apparailly F and
Noël D: Engineering mesenchymal stem cells for immunotherapy. Gene
Ther. 10:928–931. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kong QF, Sun B, Wang GY, Zhai DX, Mu LL,
Wang DD, Wang JH, Li R and Li HL: BM stromal cells ameliorate
experimental autoimmune myasthenia gravis by altering the balance
of Th cells through the secretion of IDO. Eur J Immunol.
39:800–809. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Q, Sun B, Wang D, Ji Y, Kong Q, Wang
G, Wang J, Zhao W, Jin L and Li H: Murine bone marrow mesenchymal
stem cells cause mature dendritic cells to promote T-cell
tolerance. Scand J Immunol. 68:607–615. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu Y, Ming L, Luo H, Liu W, Zhang Y, Liu
H and Jin Y: Integration of a calcined bovine bone and BMSC-sheet
3D scaffold and the promotion of bone regeneration in large
defects. Biomaterials. 34:9998–10006. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hiwatashi N, Hirano S, Mizuta M, Tateya I,
Kanemaru S, Nakamura T and Ito J: Adipose-derived stem cells versus
bone marrow-derived stem cells for vocal fold regeneration.
Laryngoscope. 124:E461–E469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kwon DS, Gao X, Liu YB, Dulchavsky DS,
Danyluk AL, Bansal M, Chopp M, McIntosh K, Arbab AS, Dulchavsky SA
and Gautam SC: Treatment with bone marrow-derived stromal cells
accelerates wound healing in diabetic rats. Int Wound J. 5:453–463.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sun L, Fan X, Zhang L, Shi G, Aili M, Lu
X, Jiang T and Zhang Y: Bone mesenchymal stem cell transplantation
via four routes for the treatment of acute liver failure in rats.
Int J Mol Med. 34:987–996. 2014.PubMed/NCBI
|
|
46
|
Li T, Zhu J, Ma K, Liu N, Feng K, Li X,
Wang S and Bie P: Autologous bone marrow-derived mesenchymal stem
cell transplantation promotes liver regeneration after portal vein
embolization in cirrhotic rats. J Surg Res. 184:1161–1173. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Schorr O, Borel C, Trepo C, Zoulim F and
Hantz O: Effects of liver growth factors on hepadnavirus
replication in chronically infected duck hepatocytes. J Hepatol.
44:842–847. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xie C, Zheng YB, Zhu HP, Peng L and Gao
ZL: Human bone marrow mesenchymal stem cells are resistant to HBV
infection during differentiation into hepatocytes in vivo and in
vitro. Cell Biol Int. 33:493–500. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rong Q, Zhang L, Su E, Li J, Li J, Liu Z,
Huang Z, Ma W, Cao K and Huang J: Bone marrow-derived mesenchymal
stem cells are capable of mediating hepatitis B virus infection in
injured tissues. J Viral Hepat. 15:607–614. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Matysiak M, Orlowski W, Fortak-Michalska
M, Jurewicz A and Selmaj K: Immunoregulatory function of bone
marrow mesenchymal stem cells in EAE depends on their
differentiation state and secretion of PGE2. J Neuroimmunol.
233:106–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Conroy MJ, Mac Nicholas R, Grealy R,
Taylor M, Otegbayo JA, O'Dea S, Mulcahy F, Ryan T, Norris S and
Doherty DG: Circulating CD56dim natural killer cells and CD56+ T
cells that produce interferon-γ or interleukin-10 are expanded in
asymptomatic, E antigen-negative patients with persistent hepatitis
B virus infection. J Viral Hepat. 22:335–345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Murray JM and Goyal A: In silico single
cell dynamics of hepatitis B virus infection and clearance. J Theor
Biol. 366:91–102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ito H, Ando T, Ando K, Ishikawa T, Saito
K, Moriwaki H and Seishima M: Induction of hepatitis B virus
surface antigen-specific cytotoxic T lymphocytes can be
up-regulated by the inhibition of indoleamine 2,3-dioxygenase
activity. Immunology. 142:614–623. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Xue-Song L, Cheng-Zhong L, Ying Z and
Mo-Bin W: Changes of Treg and Th17 cells balance in the development
of acute and chronic hepatitis B virus infection. BMC
Gastroenterol. 12:432012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang JY, Song CH, Shi F, Zhang Z, Fu JL
and Wang FS: Decreased ratio of Treg cells to Th17 cells correlates
with HBV DNA suppression in chronic hepatitis B patients undergoing
entecavir treatment. PLoS One. 5:e138692010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Djouad F, Plence P, Bony C, Tropel P,
Apparailly F, Sany J, Noël D and Jorgensen C: Immunosuppressive
effect of mesenchymal stem cells favors tumor growth in allogeneic
animals. Blood. 102:3837–3844. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Uzawa A, Mori M, Hayakawa S, Masuda S,
Nomura F and Kuwabara S: Expression of chemokine receptors on
peripheral blood lymphocytes in multiple sclerosis and
neuromyelitis optica. BMC Neurol. 10:1132010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wang T, Zhao H, Ren H, Guo J, Xu M, Yang R
and Han ZC: Type 1 and type 2 T-cell profiles in idiopathic
thrombocytopenic purpura. Haematologica. 90:914–923.
2005.PubMed/NCBI
|
|
59
|
Ma XQ, Ma QY, Wang YY, Gu P and Wang MW:
Protein secreted by bone marrow mesenchymal stem cells and its
function. J Clin Rehab Tiss Engin Res. 13:2763–2766. 2009.
|
|
60
|
Liang C, Chen SL, Wang M, Zhai WJ, Zhou Z,
Pang AM, Feng SZ and Han MZ: Synergistic immunomodulatory effects
of interferon-gamma and bone marrow mesenchymal stem cells.
Zhonghua Xue Ye Xue Za Zhi. 34:213–216. 2013.(In Chinese).
PubMed/NCBI
|
|
61
|
Dumoutier L, Van Roost E, Ameye G, Michaux
L and Renauld JC: IL-TIF/IL-22: Genomic organization and mapping of
the human and mouse genes. Genes Immun. 1:488–494. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zhang Y, Cobleigh MA, Lian JQ, Huang CX,
Booth CJ, Bai XF and Robek MD: A proinflammatory role for
interleukin-22 in the immune response to hepatitis B virus.
Gastroenterology. 141:1897–1906. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Park O, Wang H, Weng H, Feigenbaum L, Li
H, Yin S, Ki SH, Yoo SH, Dooley S, Wang FS, et al: In vivo
consequences of liver-specific interleukin-22 expression in mice:
Implications for human liver disease progression. Hepatology.
54:252–261. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Hu WH and Ren J: Impact of hepatitis B
virus infected serum on the hepatic differentiation of human bone
marrow mesenchymal stem cells. Beijing Da Xue Xue Bao. 40:459–464.
2008.(In Chinese). PubMed/NCBI
|
